With investors and - possibly - legislators on board, Texas cannabis industry poised for growth
FacebookTwitterEmail
1of2
William “Beau” Wrigley Jr., an heir to the Wrigley chewing gum company and its former chairman, president and CEO, is now CEO of goodblend Texas formerly Surterra Wellness a Georgia company that is one of three companies licensed to cultivate and sell medical cannabis in Texas.Surterra WellnessShow MoreShow Less
2of2
THC capsules resembling a typical pill are available for medical marijuana patients to use. These capsules are sold under the Surterra Wellness brand, which parent company Parallel recently changed to the goodblend Texas brand.ParallelShow MoreShow Less
Cannabis conflict: Hempest’s move into recreational marijuana causes trouble for co-owner’s family
The Hempest on Conz Street in Northampton. The store recently added recreational marijuana to its offerings, a move that caused trouble for co-owner Jonathan Napoli’s wife, Kim Napoli, who lost her job as director of corporate and social responsibility at Parallel, parent company of the New England Treatment Access dispensary just down the street. STAFF PHOTO/GRETA JOCHEM
Published: 4/14/2021 7:48:43 PM
NORTHAMPTON When Hempest co-owner Jonathan Napoli got state approval a few months back to begin selling recreational marijuana at his Conz Street store, he figured it would be a simple transition. For years the shop had sold products made from cannabis plants, including hemp products.
Cannabis MSO Parallel moves into Illinois with $100 million acquisition mjbizdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mjbizdaily.com Daily Mail and Mail on Sunday newspapers.
Field Trip Intends to Use the Net Proceeds From the Offering for the Development of the Company’s FT-104 Novel Psychedelic Development Program, the Opening of New Field Trip Health Centers, and for Working Capital and General Corporate Purposes
Field Trip Health (OTC:FTRPF) announced that, due to strong demand, it has agreed with a syndicate of underwriters led by Bloom Burton Securities, to increase the size of its previously announced $50,000,015 bought deal offering. Pursuant to the upsized deal terms, the underwriters have agreed to purchase, on a bought deal basis, 12,750,000 common shares of Field Trip, at a price of $6.50, for aggregate gross proceeds of $82,875,000.
Clever Leaves Appoints Hank Hague As CFO
Clever Leaves Holdings Inc. (NASDAQ:CLVR) has tapped Hank Hague to oversee its financial department on the heels of being added to the Cannabis ETF (NYSE:THCX), which trades on the New York Stock Exchange.
He led finances for several public and private companies within the pharmaceutical, biomedical, and cannabis industries during his career.
Previously, Hague, who replaces Amit Pandey, served as CFO of Abacus Health Products, Inc.
Kyle Detwiler, CEO of the New York cannabis company, said Monday they are “thrilled to welcome” Hague.
“Hank has an impressive corporate background, and he has demonstrated exceptional financial and strategic leadership in his previous roles,” Detwiler added.